Overview of Cost-effectiveness Analysis-Reference-Cited by-同舟云学术

Overview of Cost-effectiveness Analysis

Published:2019-04-09 Issue:14 Volume:321 Page:1400
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Sanders Gillian D.¹²³,Maciejewski Matthew L.¹⁴⁵,Basu Anirban⁶

Affiliation:

1. Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina

2. Duke Clinical Research Institute, Duke University, Durham, North Carolina

3. Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina

4. Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina

5. Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

6. The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Departments of Pharmacy, Health, Services and Economics, University of Washington, Seattle

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/14/1400/17465048/jama_sanders_2019_gm_190002.pdf

Reference4 articles.

1. Estimating cost-effectiveness of a multimodal ovarian cancer screening program in the united states: secondary analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).;Moss;JAMA Oncol,2018

2. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.;Jacobs;Lancet,2016

3. QALYs in 2018–advantages and Concerns.;Neumann;JAMA,2018

4. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-effectiveness in Health and Medicine.;Sanders;JAMA,2016

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of expectant vs active management for treatment of persistent pregnancies of unknown location;American Journal of Obstetrics and Gynecology;2024-09

2. Economic Perspective of the Use of Wearables in Health Care: A Systematic Review;Mayo Clinic Proceedings: Digital Health;2024-09

3. Cost-Effectiveness Analyses of Non-Pharmacological and Non-Surgical Interventions in Idiopathic Parkinson’s Disease: A Systematic Review;Journal of Parkinson's Disease;2024-08-13

4. Cost-effectiveness analysis design for interventions to prevent children's oral disease;Frontiers in Oral Health;2024-07-18

5. Costs and Resources Must Impact Clinical Decision-Making in the ICU: The Case of Vasopressor Use;Critical Care Medicine;2024-07-01